Related Experiment Video
Updated: Apr 21, 2026
10:28
Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
6.1K
Direct interplay between two candidate genes in FSHD muscular dystrophy
Giulia Ferri1, Claudia H Huichalaf1, Roberta Caccia2
1Division of Regenerative Medicine, Stem Cells, and Gene Therapy, Dulbecco Telethon Institute at San Raffaele Scientific Institute, DIBIT2, 5A3, Via Olgettina 58, 20132 Milan, Italy Università Vita-Salute San Raffaele, Milan, Italy.
Human Molecular Genetics
|October 19, 2014
Summary
Facioscapulohumeral muscular dystrophy (FSHD) is linked to D4Z4 deletions. Researchers found that the DUX4 gene directly targets and upregulates the FRG1 gene, uncovering a new regulatory pathway in FSHD pathogenesis.
Area of Science:
- Genetics
- Molecular Biology
- Neuromuscular Disorders
Background:
- Facioscapulohumeral muscular dystrophy (FSHD) is a common neuromuscular disorder.
- FSHD1 is associated with D4Z4 macrosatellite copy number reduction on chromosome 4q35.
- Altered chromatin structure at the D4Z4 locus affects nearby gene expression, contributing to FSHD pathogenesis.
Purpose of the Study:
- Investigate the regulatory relationship between DUX4 and FRG1 in FSHD.
- Determine if DUX4 directly regulates FRG1 expression.
- Elucidate a novel regulatory circuit in FSHD pathogenesis.
Main Methods:
- Bioinformatic identification of DUX4 binding sites in the human FRG1 gene.
- Experimental validation of DUX4 binding to FRG1 genomic regions.
- DUX4 knockdown and overexpression studies in muscle cells.
- Reporter assays using FRG1 genomic constructs.
Main Results:
- Putative DUX4 binding sites were identified in the human FRG1 gene.
- DUX4 directly binds to these sites and upregulates endogenous FRG1 expression in healthy muscle cells.
- DUX4 knockdown reduces FRG1 expression in FSHD muscle cells.
- DUX4 activates FRG1 reporter constructs.
- Mouse Frg1 lacks DUX4 binding sites, explaining the absence of muscle phenotype in transgenic mice.
Conclusions:
- FRG1 is a direct transcriptional target of DUX4.
- This DUX4-FRG1 regulatory axis represents a novel mechanism contributing to FSHD.
- Understanding this pathway may offer new therapeutic targets for FSHD.
